Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. [electronic resource]
Producer: 20150824Description: 149-156 p. digitalISSN:- 1569-8041
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Capecitabine
- Deoxycytidine -- adverse effects
- Disease-Free Survival
- Docetaxel
- Drug Administration Schedule
- Female
- Fluorouracil -- adverse effects
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Organoplatinum Compounds -- adverse effects
- Oxaliplatin
- Prospective Studies
- Stomach Neoplasms -- drug therapy
- Taxoids -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.